The pharmaceutical field is witnessing a major shift in diabetes treatment with the emergence of GLP-1 transdermal devices. These groundbreaking delivery systems offer a likely easy choice to subcutaneous injections for individuals managing type 2 diabetes. By avoiding the need for frequent injections, GLP-1 adhesives promise to enhance … Read More